Beyond Antigen Matching: The Clinical Impact of Repeated Eplet Mismatch in Kidney Retransplantation
HLA · 2026-11 · 108 (5)
DOI: 10.1111/tan.71071 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 09.11.2026. Verfasst von João Venda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Urology, and Kidney Transplantation, ULS-Coimbra, Coimbra, Portugal. Hauptthemen laut MEDLINE: Kidney Transplantation, Histocompatibility Testing, Graft Rejection, Reoperation. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kidney retransplantation carries a higher immunological risk, and conventional HLA matching may miss relevant incompatibilities. We evaluated whether repeated eplet mismatches (REM) are associated with acute rejection. We retrospectively studied 132 recipients who underwent a second kidney transplant (2009–2024). Donor and recipient high‐resolution HLA typing was performed using next‐generation sequencing, and eplet mismatches were quantified using the HLA Epitope Registry. REM were defined as eplet mismatches shared between the first and second grafts. The primary outcome was biopsy‐proven acute rejection within 12 months. No repeated donor–recipient mismatches were identified at the allele level; however, eplet analysis revealed a median of 13 (IQR 6–21) REM per recipient: 8 (3–14) Class I and 3 (0–7) Class II. Acute rejection occurred in 19 recipients (14.4%) predominantly within the first month. Class I REM were independently associated with acute rejection (HR, 1.06; 95% CI, 1.01–1.12); traditional antigen/allele mismatch counts were not predictive. REM were not associated with short‐term graft survival. In kidney retransplantation, Class I REM predict early acute rejection and outperform conventional HLA matching for short‐term immunologic risk stratification. Incorporating eplet‐based matching into donor–recipient selection may improve risk assessment in retransplant candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Urology, and Kidney Transplantation, ULS-Coimbra, Coimbra, Portugal.
- Nephrology University Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
- Centro de Histocompatibilidade do Centro, Instituto Português do Sangue e Transplantação, University of Coimbra, Coimbra, Portugal.
- Urology University Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
ORCID-Profile: João Venda, Clara Pardinhas, Luís Rodrigues, António Martinho, Arnaldo Figueiredo, Helena Sá, Rui Alves, Rita Leal
Zitieren
APA
Venda, J., Ventura, S., Pardinhas, C., Marques, M. G., Rodrigues, L., Santos, L., Romãozinho, C., Inácio, M., Gomes, J., Martinho, A., Figueiredo, A., Sá, H., Alves, R., & Leal, R. (2026). Beyond Antigen Matching: The Clinical Impact of Repeated Eplet Mismatch in Kidney Retransplantation. HLA, 108(5). https://doi.org/10.1111/tan.71071
Vancouver
Venda J, Ventura S, Pardinhas C, Marques MG, Rodrigues L, Santos L, et al. Beyond Antigen Matching: The Clinical Impact of Repeated Eplet Mismatch in Kidney Retransplantation. HLA. 2026;108(5). doi:10.1111/tan.71071
BibTeX
@article{Venda2026,
author = {Venda, João and Ventura, Sofia and Pardinhas, Clara and Marques, Maria Guedes and Rodrigues, Luís and Santos, Lídia and Romãozinho, Catarina and Inácio, Maria and Gomes, José and Martinho, António and Figueiredo, Arnaldo and Sá, Helena and Alves, Rui and Leal, Rita},
title = {Beyond Antigen Matching: The Clinical Impact of Repeated Eplet Mismatch in Kidney Retransplantation},
journal = {HLA},
year = {2026},
volume = {108},
number = {5},
doi = {10.1111/tan.71071}
}
EUVIMED